Hepatitis B
Disease State Hub
Featured
11/11/2026
Brian McCurdy
Serologic immunity was 39.5% for hepatitis A and 27.1% for hepatitis B in a nationally representative study of US adults, with gaps across high-risk groups.
11/11/2026
07/01/2026
Anthony Calabro, MA
In two phase 3, double-blind, placebo-controlled trials of adults with noncirrhotic chronic hepatitis B virus infection receiving stable nucleoside or nucleotide analog therapy, 24 weeks of bepirovirsen...
07/01/2026
06/09/2026
Ashton L. Stahl
FDA approval gives physicians the first authorized treatment option for adults with chronic hepatitis delta virus infection.
06/09/2026
Clinical Insights
MULTIDISCIPLINARY DIALOGUE, EP. 14
MULTIDISCIPLINARY DIALOGUE, EP. 14
07/14/2024
Anil Harrison, MD
In this podcast episode, Dr Harrison discusses several case presentations of patients with abnormal laboratory values, including the evaluation of liver function test results, urinalysis results, and...
07/14/2024
06/05/2024
In this podcast, William Schaffner, MD, discusses recent updates to the Advisory Committee on Immunization Practices’ (ACIP) immunization recommendations in adults aged 65 or older, including pneumococcal,...
06/05/2024
05/02/2024
Melissa E. Badowski, PharmD, MPH
In this expert interview, Melissa E. Badowski, PharmD, MPH, provides an overview of her presentation at IDWeek 2023 titled, "Guideline Adherence to Hepatitis B Virus Screening and Vaccination in Patients...
05/02/2024
11/13/2023
Melissa E. Badowski, PharmD, MPH
In this video, Melissa E. Badowski, PharmD, MPH, discusses guidelines for hepatitis B virus (HBV) screening and vaccination in patients prescribed human immunodeficiency virus (HIV) pre-exposure prophylaxis...
11/13/2023
05/12/2023
In this podcast, Sri Banerjee, MD, PhD, MPH, MAS, discusses inflammatory biomarkers associated with disease progression of HIV, hepatitis B, and hepatitis C, including his team’s...
05/12/2023
